Mogrol glycosyltransferase and gene encoding same

US10407706B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10407706-B2
Application numberUS-201515519326-A
CountryUS
Kind codeB2
Filing dateOct 16, 2015
Priority dateOct 17, 2014
Publication dateSep 10, 2019
Grant dateSep 10, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

To provide a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme. The present invention provides a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme, and a transformant into which a mogrol glycosyltransferase gene is introduced and a method for preparing the transformant.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a mogrol glycoside comprising reacting a protein selected from the group consisting of the following (a) to (c), a UDP-sugar, and the compound represented by formula (I) to obtain a mogrol glycoside; and purifying the mogrol glycoside: (a) a protein consisting of the amino acid sequence of SEQ ID NO: 2; (b) a protein consisting of an amino acid sequence in which 1 to 45 amino acids are deleted, substituted, inserted, and/or added in the amino acid sequence of SEQ ID NO: 2 and having an activity of adding a sugar molecule to an R 1 group at position 24 of a compound represented by the following formula (I); and (c) a protein having an amino acid sequence having 90% or more sequence identity with the amino acid sequence of SEQ ID NO: 2 and having the activity of adding a sugar molecule to an R 1 group at position 24 of the compound represented by formula (I), where R and R 1 each independently represent H, a monosaccharide, or a disaccharide. 2. The method according to claim 1 , wherein the UDP-sugar is a UDP-hexose. 3. The method according to claim 1 , wherein the UDP-sugar is selected from the group consisting of UDP-glucose, UDP-mannose, and UDP-galactose. 4. The method according to claim 1 , wherein the R and R 1 is each independently H or a sugar residue of a glucose monomer or a glucose dimer. 5. The method according to claim 1 , wherein the compound represented by formula (I) is mogrol or a mogrol glycoside. 6. The method according to claim 1 , which yields mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside II 1 , mogroside IIE, mogroside III, mogroside IIIA 1 , mogroside IIIA 2 , mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof. 7. The method according to claim 2 , which yields mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA 1 , mogroside IIE, mogroside III, mogroside IIIA 1 , mogroside IIIA 2 , mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof. 8. The method according to claim 3 , which yields mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA 1 , mogroside IIE, mogroside III, mogroside IIIA 1 , mogroside IIIA 2 , mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof. 9. The method according to claim 4 , which yields mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA 1, mogroside IIE, mogroside III, mogroside IIIA 1 , mogroside IIIA 2 , mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof. 10. The method according to claim 5 , which yields mogroside IA, mogroside Ib, mogroside IE, mogroside IIA, mogroside IIA 1 , mogroside IIE, mogroside III, mogroside IIIA 1 , mogroside IIIA 2 , mogroside IIIE, mogroside IV, mogroside IVA, mogroside V, siamenoside I, 11-oxomogroside V, mogrol pentaglycoside, or a combination thereof.

Assignees

Inventors

Classifications

  • Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title

  • Genes encoding for enzymes or proenzymes · CPC title

  • Bacteria; Culture media therefor · CPC title

  • Yeasts; Culture media therefor · CPC title

  • Preparation of steroids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10407706B2 cover?
To provide a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme. The present invention provides a mogrol glycosyltransferase and a method for producing a mogrol glycoside using the enzyme, and a transformant into which a mogrol glycosyltransferase gene is introduced and a method for preparing the transformant.
Who is the assignee on this patent?
Suntory Holdings Ltd
What technology area does this patent fall under?
Primary CPC classification C07J9/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).